Can Last Year's Biggest Vaccine Stocks Crush the Market Again?

·6 min read
Can Last Year's Biggest Vaccine Stocks Crush the Market Again?

Coronavirus vaccine stocks were the biggest investment theme of 2020. Since, two biotech companies -- Moderna (NASDAQ: MRNA) and BioNTech -- actually have commercialized their vaccines. Let's take a look at where they're at with vaccine programs -- and whether they're on track to beat the market in the second half.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting